Blood Pressure Lowering in Patients with Left Ventricular Hypertrophy - Navigating between Scylla and Charybdis.

IF 3.1 3区医学 Q2 PHARMACOLOGY & PHARMACY

Journal of Pharmacology and Experimental Therapeutics Pub Date : 2024-06-21 DOI:10.1124/jpet.123.002093

Renate Schoenenberger-Berzins, Franz H Messerli

引用次数: 0

查看原文本刊更多论文

左心室肥大患者的降压治疗--在 Scylla 和 Charybdis 之间游刃有余。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Pharmacology and Experimental Therapeutics 医学-药学

CiteScore

6.90

自引率

0.00%

发文量

115

审稿时长

1 months

期刊介绍： A leading research journal in the field of pharmacology published since 1909, JPET provides broad coverage of all aspects of the interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as analgesics, drug abuse, metabolism and disposition, chemotherapy, and toxicology.